Literature DB >> 6847469

Nitrous oxide cryotherapy for intraepithelial epithelioma of the conjunctiva.

R D Divine, R L Anderson.   

Abstract

Nine patients were treated with the nitrous oxide eyelid cryoprobe for large or recurrent intraepithelial epithelioma of the conjunctiva or cornea. Nitrous oxide cryotherapy is more convenient for ocular cryosurgery than liquid nitrogen therapy and seems to be as effective for intraepithelial epithelioma. Surgical debulking of the lesion is recommended before cryosurgery. An obvious advantage of cryosurgery over surgical modalities for intraepithelial epithelioma is that large areas of tumor as well as surrounding tissues can be treated. This procedure results in a higher cure rate and avoids grafting and symblepharon formation. The complications of light cryosurgery seem to be minor even when the cornea is treated. Heavy cryosurgery may result in severe iritis, posterior synechiae, and corneal scarring. A biopsy-proved diagnosis of intraepithelial epithelioma can be misleading and does not rule out the presence of underlying malignant disease.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6847469     DOI: 10.1001/archopht.1983.01040010782018

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  4 in total

1.  Beta radiation of recurrent corneal intraepithelial neoplasia.

Authors:  D B Jones; K R Wilhelmus; R L Font
Journal:  Trans Am Ophthalmol Soc       Date:  1991

2.  Ocular surface squamous neoplasia in xeroderma pigmentosum: clinical spectrum and outcome.

Authors:  Noopur Gupta; Ritika Sachdev; Radhika Tandon
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-04-12       Impact factor: 3.117

3.  Long-term follow-up of invasive ocular surface squamous cell carcinoma treated with excision, cryotherapy, and topical mitomycin C.

Authors:  Mohsen Bahmani Kashkouli; Abtin Heirati; Farzad Pakdel; Victoria Kiavash; Masood Naseripour; Farzaneh Aghamohammadi
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-02-03       Impact factor: 3.117

4.  Topical treatment options for conjunctival neoplasms.

Authors:  Jonathan W Kim; David H Abramson
Journal:  Clin Ophthalmol       Date:  2008-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.